A groundbreaking international study has found that imlunestrant plus abemaciclib significantly improved progression-free survival (PFS) versus imlunestrant monotherapy in patients with estrogen ...

An unfortunate statistic of ovarian cancer is that one out of 57 women who visit the clinic have ovarian tumors and approximately 60% of them are already in advanced stage (National Cancer Institute).

Multiple omics researches in the past two decades have identified over 200 potential biomarkers for ovarian cancer. Discoveries during the 1990s were more focused on clinicopathology-based ...

The development of ZnO-based biosensors targeting CYFRA 21-1 represents a significant advancement in cancer detection technology. With its potential for rapid, sensitive, and noninvasive screening ...

“Crohn’s disease in particular involves any part of the GI tract, anywhere from the oral cavity down to the colon and the anus,” says Dr. Shirley Cohen-Mekelburg, a spokesperson for the ...

The aim of this guidance is to ensure equitable access to oral healthcare for patients diagnosed with cancer across England. It provides clinical standards and example pathways to maximize cancer ...

Researchers have therefore been trying for years to develop highly sensitive biosensors that utilize their properties. Graphene-based field-effect transistors, for example, could register the ...